Myeloproliferative Disorders Drugs Market Driven by Rising Focus on Precision Drugs
The global myeloproliferative disorders drugs market size was estimated at USD 11.34 billion in 2024 and is projected to reach USD 15.83 billion by 2030, growing at a CAGR of 5.9% from 2025 to 2030. The increasing prevalence of myeloproliferative disorders, particularly among older adults, is a major contributor to market expansion. According to the National Institute of Health,...
0 ความคิดเห็น 0 หุ้น 5 มุมมอง 0 บทวิจารณ์